Listed below are clinical trials that have opened at SCCA in the last several weeks. These trials are looking at new treatments for adult patients with prostate cancer, multiple myeloma, acute myeloid leukemia, lymphoma and perivascular epitheliod cell tumors. Check out our website to learn about the more than 200 ongoing clinical trials at SCCA, and follow us on Twitter at @SCCA_Trials for information about recently opened trials.
Mobilization and Treatment of Disseminated Tumor Cells for Metastatic Prostate Cancer (9297)
A Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men with Metastatic Prostate Cancer
Pomalidomide/Dexamethasone With or Without Elotuzumab for Multiple Myeloma (20160970)
An Open Label, Randomized Phase 2 Trial of Pomalidomide/Dexamethasone With or Without Elotuzumab in relapsed and refractory Multiple Myeloma
Vadastuximab Talirine with Allogeneic Hematopoietic Stem Cell Transplant for Acute Myeloid Leukemia (9556)
A Phase 1/2 Study of Vadastuximab Talirine Administered in Sequence with Allogeneic Hematopoietic Stem Cell Transplant in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
AMG 330 Administered as Continuous Intravenous Infusion for Acute Myeloid Leukemia (9382)
A Phase 1 First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 330 Administered as Continuous Intravenous Infusion in Subjects with Relapsed/Refractory Acute Myeloid Leukemia
Denintuzumab Mafodotin plus RICE vs. RICE Alone for Large B-cell Lymphoma (20151683)
A randomized, open-label phase 2 study of denintuzumab mafodotin (SGN-CD19A) plus rituximab, ifosfamide, carboplatin, and etoposide (19A+RICE) chemotherapy vs. RICE in the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are candidates for autologous stem cell transplant.
ABI-009 for Perivascular Epithelioid Cell Tumors (PEComa)
A phase 2 multi-center investigation of efficacy of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa)